Tg Therapeutics Inc (TGTX)

Financing Cash Flow

$313.73M

TTM · Period ending: · USD

TGTX logo

TGTX Financing Cash Flow

Latest reported$313.73M
TGTX TTM Cash from Financing ($10.60M → $313.73M)
High-resolution chart · PNG

TGTX financing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Tg Therapeutics Inc Financing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingFinancing Cash Flow (USD)
313,730,000
307,202,000
-89,729,000
-96,859,000
115,837,000
122,415,000
128,527,000
134,598,000
565,000
47,477,000
72,705,000
72,755,000
72,609,000
25,697,000
-391,000
55,557,000
47,921,000
40,624,000
41,419,000
388,811,000
431,437,000
679,691,000
679,827,000
374,792,000
360,222,000
147,414,000
204,213,000
110,553,000
94,350,000
118,089,000
113,639,000
123,682,079
147,406,356
99,179,970
133,658,626
120,342,343
92,170,696
91,910,462
5,015,969
3,616,761
19,316,143
33,407,952
68,723,686
95,429,804
103,885,922
86,530,506
68,643,526
42,049,296
55,771,208
56,285,251
39,779,254
39,561,239
1,639,197
796,894
11,896,867
21,906,088
21,936,203
130,115
-12,006,778
-21,987,015
-22,100,463
-270,482
1,914,264
2,161,321
2,244,654
2,276,248
961,772
1,760,413
1,826,359
2,720,906
3,909,319
-4,955,494
-5,023,408
-5,904,605
-15,257
7,859,413
7,861,381
7,842,941
-15,256
15,073
11,921,150
11,619,190
11,698,401
11,668,072
-246,719
15,908
3,390,528
12,417,458
12,375,118
12,419,541
8,983,567
-43,363
7,396
9,063
-37,444
1,902,517
1,902,402
1,089,621
510,793
-1,940,976
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.